Anne-marie Hacker
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safe.
Journal: European radiology
Published: January 15, 2026
Symptom prevalence and impact on lung cancer risk in the SUMMIT study.
Journal: Chest
Published: April 25, 2025
Differentiating clinically important interstitial lung abnormalities in lung cancer screening.
Journal: BMJ open respiratory research
Published: March 14, 2025
Incidence rate and malignancy risk in new nodules in a lung cancer screening programme.
Journal: European radiology
Published: November 18, 2024
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.
Journal: Lancet (London, England)
Published: October 17, 2024
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study.
Journal: The Lancet. Oncology
Published: September 24, 2024
Impact of Low-Dose Computed Tomography Findings on Cigarette Smoking Cessation Among High-Risk Adults Participating in Lung Cancer Screening.
Journal: Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
Published: July 09, 2024
Uptake and 4-week outcomes of an 'opt-out' smoking cessation referral strategy in a London-based lung cancer screening setting.
Journal: BMJ open respiratory research
Published: January 25, 2024
Prevalence and clinical characteristics of non-malignant CT detected incidental findings in the SUMMIT lung cancer screening cohort.
Journal: BMJ open respiratory research
Published: February 08, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026